Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23660272)

1.

A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.

Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM.

Biol Psychiatry. 2013 Sep 15;74(6):436-43. doi: 10.1016/j.biopsych.2013.03.017. Epub 2013 May 6.

2.

Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.

Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH.

Neuropsychopharmacology. 1999 Aug;21(2):195-202.

3.

Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.

Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1184-90.

PMID:
16187778
4.

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP.

Arch Gen Psychiatry. 2005 Jun;62(6):649-59.

PMID:
15939842
5.

Effects of bupropion on cognitive performance during initial tobacco abstinence.

Perkins KA, Karelitz JL, Jao NC, Gur RC, Lerman C.

Drug Alcohol Depend. 2013 Nov 1;133(1):283-6. doi: 10.1016/j.drugalcdep.2013.05.003. Epub 2013 May 31.

6.

Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls.

Drusch K, Lowe A, Fisahn K, Brinkmeyer J, Musso F, Mobascher A, Warbrick T, Shah J, Ohmann C, Winterer G, Wölwer W.

Eur Arch Psychiatry Clin Neurosci. 2013 Sep;263(6):519-27. doi: 10.1007/s00406-012-0377-9. Epub 2012 Oct 19.

PMID:
23081705
7.

Nicotine self-medication of cognitive-attentional processing.

Evans DE, Drobes DJ.

Addict Biol. 2009 Jan;14(1):32-42. doi: 10.1111/j.1369-1600.2008.00130.x. Epub 2008 Oct 9. Review.

PMID:
18855804
8.

Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia.

AhnAllen CG, Nestor PG, Shenton ME, McCarley RW, Niznikiewicz MA.

Schizophr Res. 2008 Mar;100(1-3):261-9. Epub 2007 Sep 19.

9.

Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.

Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J.

J Clin Psychopharmacol. 2008 Dec;28(6):667-74. doi: 10.1097/JCP.0b013e31818c9bb8.

PMID:
19011436
10.

Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls.

Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG.

Nicotine Tob Res. 2013 Jan;15(1):121-9. doi: 10.1093/ntr/nts098. Epub 2012 Apr 19.

11.

Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.

Amitai N, Markou A.

Psychopharmacology (Berl). 2009 Jan;202(1-3):275-86. doi: 10.1007/s00213-008-1246-0. Epub 2008 Jul 11.

12.

Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia.

Moss TG, Sacco KA, Allen TM, Weinberger AH, Vessicchio JC, George TP.

Drug Alcohol Depend. 2009 Sep 1;104(1-2):94-9. doi: 10.1016/j.drugalcdep.2009.04.005. Epub 2009 May 17.

13.

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.

George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR.

Am J Psychiatry. 2000 Nov;157(11):1835-42.

PMID:
11058482
14.

Smoking history, nicotine dependence, and changes in craving and mood during short-term smoking abstinence in alcohol dependent vs. control smokers.

Heffner JL, Mingione C, Blom TJ, Anthenelli RM.

Addict Behav. 2011 Mar;36(3):244-7. doi: 10.1016/j.addbeh.2010.10.008. Epub 2010 Oct 28.

15.

Nicotine patches and the subjective effects of cigarette smoking: a pilot study.

Cárdenas L, Busto UE, MacDonald A, Corrigall WA.

Can J Clin Pharmacol. 2002 Winter;9(4):175-82.

PMID:
12584575
16.
17.

[A review of the effects of nicotine on schizophrenia].

Bidzan L.

Psychiatr Pol. 2007 Sep-Oct;41(5):737-44. Review. Polish.

PMID:
18421928
18.

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI.

Biol Psychiatry. 2008 Jun 1;63(11):1092-6. Epub 2007 Dec 21.

19.

Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence.

Dawkins L, Powell JH, Pickering A, Powell J, West R.

Addiction. 2009 May;104(5):850-8. doi: 10.1111/j.1360-0443.2009.02522.x. Epub 2009 Mar 13.

20.

Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.

Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):111-8. doi: 10.1016/j.drugalcdep.2011.03.005. Epub 2011 Apr 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk